Topiramate D12
Based on 1 Customer Validation
Topiramate D12 (McN 4853 D12) is a deuterium labeled Topiramate. Topiramate is a broad-spectrum antiepileptic agent. Topiramate is a GluR5 receptor antagonist. Topiramate produces its antiepileptic effects through enhancement of GABAergic activity, inhibition of kainate/AMPA receptors, inhibition of voltage-sensitive sodium and calcium channels, increases in potassium conductance, and inhibition of carbonic anhydrase.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 1279037-95-4
- 分子式: C12H9D12NO8S
- 分子量:351.44
-
保管条件:Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
生物活性
-
化学情報
- 純度とドキュメンテーション
- 参考文献
-
Help & FAQs
-
HY-110234R
Topiramate D12 (Standard)Antiepileptic Agent -
HY-B0185
LidocaineNa+ Channel Blocker -
HY-B0934
EthylparabenAntifungal Agent -
HY-B0246
CarbamazepineAnticonvulsant -
HY-B0185R
Lidocaine (Standard) -
HY-B0211
RiluzoleAnticonvulsant Agent -
HY-B0122
TopiramateAntiepileptic Agent -
HY-W033577
Tricarbonyldichlororuthenium(II) dimerCO Donor -
HY-B0246R
Carbamazepine (Standard)Anticonvulsant -
HY-B1480
EthoxzolamideCarbonic Anhydrase Inhibitor -
HY-N2877
AnnonacinMitochondrial Complex I Inhibitor -
HY-B0185A
Lidocaine hydrochlorideNa+ Channel Blocker
生物活性
製品説明
IC50 & Target
|
Kainate Receptor |
アプリケーション
1. This compound can be used as a tracer
2. This compound can be used as an internal standard for quantitative analysis by NMR, GC-MS, or LC-MS.
化学情報
-
CAS 番号 1279037-95-4
-
非標識Cas 97240-79-4
-
性状 Solid
-
分子量 351.44
-
分子式 C12H9D12NO8S
-
SMILES
NS(OC[C@]12[C@](OC(C([2H])([2H])[2H])(C([2H])([2H])[2H])O2)([H])[C@@]3([H])[C@@](OC(C([2H])([2H])[2H])(C([2H])([2H])[2H])O3)([H])CO1)(=O)=O
-
別名
McN 4853 D12 ; RWJ 17021 D12
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Powder -20°C 3 years In solvent -80°C 6 months -20°C 1 month
純度とドキュメンテーション
-
データシート (275 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
-
取扱説明書 (2659 KB)
参考文献
[1]. Kaminski RM, et al. Topiramate selectively protects against seizures induced by ATPA, a GluR5 kainate receptor agonist. Neuropharmacology. 2004 Jun;46(8):1097-104. [Content Brief]
[2]. Lyseng-Williamson KA, et al. Topiramate: a review of its use in the treatment of epilepsy. Drugs. 2007;67(15):2231-56. [Content Brief]
[3]. Nakamura J, et al. Target pharmacology of topiramate, a new antiepileptic drug. Nihon Yakurigaku Zasshi. 2000 Jan;115(1):53-7. [Content Brief]
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
Topiramate D12 関連分類
HY-110234 関連分類
Powered by Bioz